Halley E. Gilbert - 12 Jun 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Reporting relationship: Director
Issuer ticker: PCVX
Reported as of: 12 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jun 2025, 18:10:41 UTC
Prior SEC filing: 13 Jun 2025
Next SEC filing: 21 Nov 2025
Source filing: View source filing
Reporting owner signature: Halley E. Gilbert, by /s/ Peter N. Efremenko, Attorney-In-Fact

Key filing fact

Halley E. Gilbert filed Form 4 for Vaxcyte, Inc. (PCVX) on 16 Jun 2025.

Key facts

This page summarizes Halley E. Gilbert's Form 4 filing for Vaxcyte, Inc. (PCVX).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 16 Jun 2025, 18:10.

Change

Previous filing in this sequence was filed on 13 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001601360 Primary reporting owner

Gilbert Halley E

Relationship: Director
Address: C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS
Signature: Halley E. Gilbert, by /s/ Peter N. Efremenko, Attorney-In-Fact
Signature date: 16 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PCVX transaction

Common Stock

Award

Transaction value: $0
Shares: +3,041
Change %: +42%
Price: $0.000000
Shares after: 10,216
Date: 12 Jun 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PCVX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +15,372
Change %
Price: $0.000000
Shares after: 15,372
Date: 12 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,372
Exercise price: $34.46
Footnotes: F4

PCVX holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 13,500
Date: 12 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,500
Exercise price: $5.35
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Footnote F2

Option is fully vested and exercisable.

Footnote F3

On July 25, 2024, Reporting Person transferred 16,874 vested stock options to Reporting Person's ex-spouse pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. Accordingly, Reporting Person will not report beneficial ownership of or dispositions or acquisitions of the underlying shares in future Section 16(a) filings.

Footnote F4

The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 12, 2026 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.